Trader consensus on Polymarket reflects a 92.6% implied probability against a new coronavirus pandemic in 2026, driven by the absence of any World Health Organization (WHO) declaration of a Public Health Emergency of International Concern (PHEIC) or pandemic for a novel coronavirus distinct from SARS-CoV-2, as confirmed by real-time global surveillance from CDC and WHO networks. Current strains, such as the Omicron subvariant BA.3.2 ("Cicada"), are spreading seasonally in the US and 30+ countries but represent evolutionary changes within the existing virus, not a new pathogen, with no evidence of exponential global transmission or heightened severity beyond baseline endemic levels. This positioning aligns with historical post-COVID patterns, bolstered by advanced genomic monitoring and the 2025 WHO Pandemic Agreement enhancing preparedness. Realistic challenges include undetected zoonotic spillovers from animal reservoirs or rapid emergence in under-surveilled regions, with key updates expected from WHO's May 2026 vaccine antigen deliberations.